We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...
AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced the successful completion of an oversubscribed US$112 million Series C financing ...
SYDNEY, February 03, 2025--(BUSINESS WIRE)--AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced the successful completion of an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback